tiprankstipranks
Trending News
More News >
Medical Properties Trust, Inc. (DE:M3P)
NYSE:M3P
Germany Market

Medical Properties Trust (M3P) Stock Forecast & Price Target

Compare
15 Followers
See the Price Targets and Ratings of:

M3P Analyst Ratings

Hold
4Ratings
Hold
2 Buy
1 Hold
1 Sell
Based on 4 analysts giving stock ratings to
Medical
Properties Trust
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

M3P Stock 12 Month Forecast

Average Price Target

€5.64
▲(11.24% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Medical Properties Trust in the last 3 months. The average price target is €5.64 with a high forecast of €6.76 and a low forecast of €4.23. The average price target represents a 11.24% change from the last price of €5.07.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","7":"€7","3.25":"€3.25","4.5":"€4.5","5.75":"€5.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6.76456112,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€6.76</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.6399528338,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€5.64</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.2278507,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€4.23</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,3.25,4.5,5.75,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.18,4.378812393846154,4.577624787692307,4.776437181538461,4.975249575384615,5.1740619692307686,5.372874363076923,5.571686756923077,5.770499150769231,5.969311544615384,6.168123938461538,6.3669363323076915,6.565748726153846,{"y":6.76456112,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.18,4.292304064138461,4.404608128276923,4.5169121924153846,4.629216256553846,4.741520320692308,4.853824384830769,4.966128448969231,5.078432513107692,5.190736577246153,5.303040641384615,5.415344705523077,5.527648769661538,{"y":5.6399528338,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.18,4.183680823076923,4.187361646153846,4.191042469230769,4.1947232923076925,4.198404115384616,4.202084938461539,4.205765761538461,4.209446584615384,4.2131274076923075,4.216808230769231,4.220489053846154,4.224169876923077,{"y":4.2278507,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.237,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.222,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.126,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.576,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.701,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.55,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.403,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.746,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.5,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.389,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.811,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.291,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.18,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€6.76Average Price Target€5.64Lowest Price Target€4.23
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
KeyBanc
Hold
Reiterated
02/20/26
Analysts Offer Insights on Real Estate Companies: Broadstone Net Lease (NYSE: BNL) and Medical Properties Trust (NYSE: MPT)
Maxim Group Analyst forecast on DE:M3P
Maxim Group
Maxim Group
€6.79
Buy
33.85%
Upside
Reiterated
02/20/26
Analysts Have Conflicting Sentiments on These Real Estate Companies: Cushman & Wakefield (NYSE: CWK) and Medical Properties Trust (NYSE: MPT)
Colliers Securities Analyst forecast on DE:M3P
Colliers Securities
Colliers Securities
€5.09€5.94
Buy
17.12%
Upside
Reiterated
02/19/26
Analysts Are Bullish on These Real Estate Stocks: Goodman Group (GMGSF), Medical Properties Trust (MPT)
Wells Fargo Analyst forecast on DE:M3P
Wells Fargo
Wells Fargo
€3.82€4.24
Sell
-16.35%
Downside
Reiterated
11/25/25
Wells Fargo Sticks to Their Sell Rating for Medical Properties (MPW)
Bank of America Securities Analyst forecast on DE:M3P
Bank of America Securities
Bank of America Securities
€3.39€3.82
Sell
-24.71%
Downside
Reiterated
11/17/25
Medical Properties Trust price target raised to $4.50 from $4 at BofAMedical Properties Trust price target raised to $4.50 from $4 at BofA
RBC Capital Analyst forecast on DE:M3P
RBC Capital
RBC Capital
€3.82
Hold
-24.71%
Downside
Reiterated
11/14/25
Medical Properties (MPW) Gets a Hold from RBC Capital
Exane BNP Paribas Analyst forecast on DE:M3P
Exane BNP Paribas
Exane BNP Paribas
€4.24€7.63
Buy
50.58%
Upside
Upgraded
03/11/25
Medical Properties Trust upgraded to Outperform from Neutral at Exane BNP ParibasMedical Properties Trust upgraded to Outperform from Neutral at Exane BNP Paribas
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
KeyBanc
Hold
Reiterated
02/20/26
Analysts Offer Insights on Real Estate Companies: Broadstone Net Lease (NYSE: BNL) and Medical Properties Trust (NYSE: MPT)
Maxim Group Analyst forecast on DE:M3P
Maxim Group
Maxim Group
€6.79
Buy
33.85%
Upside
Reiterated
02/20/26
Analysts Have Conflicting Sentiments on These Real Estate Companies: Cushman & Wakefield (NYSE: CWK) and Medical Properties Trust (NYSE: MPT)
Colliers Securities Analyst forecast on DE:M3P
Colliers Securities
Colliers Securities
€5.09€5.94
Buy
17.12%
Upside
Reiterated
02/19/26
Analysts Are Bullish on These Real Estate Stocks: Goodman Group (GMGSF), Medical Properties Trust (MPT)
Wells Fargo Analyst forecast on DE:M3P
Wells Fargo
Wells Fargo
€3.82€4.24
Sell
-16.35%
Downside
Reiterated
11/25/25
Wells Fargo Sticks to Their Sell Rating for Medical Properties (MPW)
Bank of America Securities Analyst forecast on DE:M3P
Bank of America Securities
Bank of America Securities
€3.39€3.82
Sell
-24.71%
Downside
Reiterated
11/17/25
Medical Properties Trust price target raised to $4.50 from $4 at BofAMedical Properties Trust price target raised to $4.50 from $4 at BofA
RBC Capital Analyst forecast on DE:M3P
RBC Capital
RBC Capital
€3.82
Hold
-24.71%
Downside
Reiterated
11/14/25
Medical Properties (MPW) Gets a Hold from RBC Capital
Exane BNP Paribas Analyst forecast on DE:M3P
Exane BNP Paribas
Exane BNP Paribas
€4.24€7.63
Buy
50.58%
Upside
Upgraded
03/11/25
Medical Properties Trust upgraded to Outperform from Neutral at Exane BNP ParibasMedical Properties Trust upgraded to Outperform from Neutral at Exane BNP Paribas
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
Find stocks in the Real Estate sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medical Properties Trust

3 Months
xxx
Success Rate
3/6 ratings generated profit
50%
Average Return
-4.82%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -4.82% per trade.
1 Year
Barry OxfordColliers Securities
Success Rate
5/6 ratings generated profit
83%
Average Return
+13.62%
a rating ―
Copying Barry Oxford's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +13.62% per trade.
2 Years
xxx
Success Rate
6/6 ratings generated profit
100%
Average Return
+16.78%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +16.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

M3P Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
1
Buy
1
1
1
1
2
Hold
2
3
1
1
1
Sell
1
3
3
3
0
Strong Sell
0
0
0
0
0
total
4
7
5
5
4
In the current month, M3P has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. M3P average Analyst price target in the past 3 months is 5.64.
Each month's total comprises the sum of three months' worth of ratings.

M3P Financial Forecast

M3P Earnings Forecast

Next quarter’s earnings estimate for M3P is <€0.01 with a range of €0.00 to €0.02. The previous quarter’s EPS was €0.03. M3P beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.64% of the time in the same period. In the last calendar year M3P has Performed in-line its overall industry.
Next quarter’s earnings estimate for M3P is <€0.01 with a range of €0.00 to €0.02. The previous quarter’s EPS was €0.03. M3P beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 49.64% of the time in the same period. In the last calendar year M3P has Performed in-line its overall industry.

M3P Sales Forecast

Next quarter’s sales forecast for M3P is €205.23M with a range of €193.33M to €214.01M. The previous quarter’s sales results were €228.59M. M3P beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year M3P has Performed in-line its overall industry.
Next quarter’s sales forecast for M3P is €205.23M with a range of €193.33M to €214.01M. The previous quarter’s sales results were €228.59M. M3P beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 72.47% of the time in the same period. In the last calendar year M3P has Performed in-line its overall industry.

M3P Stock Forecast FAQ

What is DE:M3P’s average 12-month price target, according to analysts?
Based on analyst ratings, Medical Properties Trust, Inc.’s 12-month average price target is 5.64.
    What is DE:M3P’s upside potential, based on the analysts’ average price target?
    Medical Properties Trust, Inc. has 11.24% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Medical Properties Trust, Inc. a Buy, Sell or Hold?
          Medical Properties Trust, Inc. has a consensus rating of Hold, which is based on 2 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Medical Properties Trust, Inc.’s share price target?
            The average share price target for Medical Properties Trust, Inc. is 5.64. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €6.76 ,and the lowest forecast is €4.23. The average share price target represents 11.24% Increase from the current price of €5.07.
              What do analysts say about Medical Properties Trust, Inc.?
              Medical Properties Trust, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Medical Properties Trust, Inc.?
                To buy shares of DE:M3P, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.